117 related articles for article (PubMed ID: 34791360)
1. Comparison of clinical features and outcomes of patients with leiomyosarcoma of bone and soft tissue: a population-based cohort study.
Kobayashi H; Zhang L; Hirai T; Tsuda Y; Ikegami M; Tanaka S
Jpn J Clin Oncol; 2022 Feb; 52(2):143-150. PubMed ID: 34791360
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinicopathological features and outcomes in patients with primary leiomyosarcoma of bone and soft tissue.
Gusho CA; Blank AT; Gitelis S
J Surg Oncol; 2021 Apr; 123(5):1274-1283. PubMed ID: 33524203
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
[TBL] [Abstract][Full Text] [Related]
4. Leiomyosarcoma of the head and neck: a population-based analysis.
Eppsteiner RW; DeYoung BR; Milhem MM; Pagedar NA
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):921-4. PubMed ID: 21930982
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma.
Tsiatis AC; Herceg ME; Keedy VL; Halpern JL; Holt GE; Schwartz HS; Cates JM
Mod Pathol; 2009 Nov; 22(11):1432-8. PubMed ID: 19633646
[TBL] [Abstract][Full Text] [Related]
6. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment outcomes in patients with pleomorphic rhabdomyosarcoma: a population-based cohort study.
Kobayashi H; Okajima K; Zhang L; Hirai T; Ishibashi Y; Tsuda Y; Ikegami M; Kawai A; Tanaka S
Jpn J Clin Oncol; 2024 Apr; 54(4):471-478. PubMed ID: 38183215
[TBL] [Abstract][Full Text] [Related]
8. The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso.
Schwartz DL; Einck J; Hunt K; Bruckner J; Conrad E; Koh WJ; Laramore GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1352-9. PubMed ID: 11955749
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.
Svarvar C; Böhling T; Berlin O; Gustafson P; Follerås G; Bjerkehagen B; Domanski HA; Sundby Hall K; Tukiainen E; Blomqvist C;
Cancer; 2007 Jan; 109(2):282-91. PubMed ID: 17154171
[TBL] [Abstract][Full Text] [Related]
10. Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival.
Baudo A; Piccinelli ML; Incesu RB; Morra S; Scheipner L; Barletta F; Tappero S; Garcia CC; Assad A; Tian Z; Acquati P; de Cobelli O; Longo N; Briganti A; Terrone C; Chun FKH; Tilki D; Ahyai S; Saad F; Shariat SF; Carmignani L; Karakiewicz PI
Surg Oncol; 2024 Jun; 54():102074. PubMed ID: 38615387
[TBL] [Abstract][Full Text] [Related]
11. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
12. Oncological and prognostic analysis of soft tissue sarcoma of the elbow: report using the bone and soft tissue tumor registry in Japan.
Emori M; Iba K; Murahashi Y; Shimizu J; Sonoda T; Wada T; Yamashita T; Kawai A
Jpn J Clin Oncol; 2021 Nov; 51(11):1608-1614. PubMed ID: 34322711
[TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant chemotherapy in patients with localized, undifferentiated pleomorphic sarcoma of soft tissue: a population-based cohort study.
Kobayashi H; Zhang L; Hirai T; Tsuda Y; Ikegami M; Tanaka S
Int J Clin Oncol; 2022 Apr; 27(4):802-810. PubMed ID: 35064354
[TBL] [Abstract][Full Text] [Related]
16. Outcome and prognosis in retroperitoneal soft tissue sarcoma.
Catton CN; O'Sullivan B; Kotwall C; Cummings B; Hao Y; Fornasier V
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1005-10. PubMed ID: 8083069
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and prognostic factors for a consecutive case series of 115 patients with somatic leiomyosarcoma.
Abraham JA; Weaver MJ; Hornick JL; Zurakowski D; Ready JE
J Bone Joint Surg Am; 2012 Apr; 94(8):736-44. PubMed ID: 22517390
[TBL] [Abstract][Full Text] [Related]
19. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of undifferentiated pleomorphic sarcoma of bone and the impact of adjuvant chemotherapy on the affected patients: a population-based cohort study.
Kobayashi H; Zhang L; Hirai T; Tsuda Y; Ikegami M; Tanaka S
Jpn J Clin Oncol; 2022 May; 52(6):589-598. PubMed ID: 35184191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
